Clinical Trials

Rectal Neoplasms

NCT03698461 2024-01-31

CLIMB

20 enrolled

Phase NA Not yet recruiting

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT06035133 2023-09-13

Treatment of Low Locally Advanced Rectal Cancer With Radiotherapy Removal TNT Plus Neoadjuvant Therapy

213 enrolled

Rectal Neoplasms

NCT01871571 2022-08-09

Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer

Phase 2 Unknown

17 enrolled

Rectal Neoplasms

NCT00308516 2021-12-10

5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer

66 enrolled 6 charts

Rectal Neoplasms, Colorectal Neoplasms

NCT01280643 2021-03-15

Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Phase NA Terminated

3 enrolled 8 charts

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00423696 2021-02-17

Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

145 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01481545 2021-02-03

BRANCH

62 enrolled 13 charts

Rectal Neoplasms

NCT00628810 2020-11-09

Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

86 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01417494 2020-11-03

1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer

102 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT04213222 2020-08-11

ROBOT

Unknown

300 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00265850 2020-05-07

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Phase 3 Completed

2,334 enrolled 9 charts

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00602329 2020-04-28

MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer

5 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00541125 2020-03-30

G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer

20 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00952029 2020-03-30

Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer

Phase 2/3 Completed

492 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00544700 2020-02-20

Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer

Phase 3 Terminated

265 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01923987 2019-09-20

Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis

Phase 2 Unknown

39 enrolled

Rectal Neoplasms

NCT00828672 2019-07-10

AXEBEAM

84 enrolled 19 charts

Postoperative Complications, Rectal Neoplasms

NCT01206530 2019-04-18

FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer

Phase 1/2 Completed

50 enrolled

Adenocarcinoma, Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms

NCT03085992 2018-03-14

TRUST

49 enrolled

Rectal Neoplasms

NCT01279681 2017-12-08

Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer

Phase 3 Terminated

32 enrolled 14 charts

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Neurotoxicity Syndromes

NCT00847119 2017-08-29

xeberecto

43 enrolled

Adenocarcinoma, Rectal Neoplasms

NCT00408772 2017-06-09

Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer

Phase 2 Withdrawn

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00449163 2017-05-11

Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer

25 enrolled 10 charts

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00307736 2017-05-10

Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer

Phase 1/2 Completed

32 enrolled 14 charts

Rectal Neoplasms

NCT00127036 2017-03-23

Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)

65 enrolled 8 charts

Adenocarcinoma, Colonic Neoplasms, Rectal Neoplasms

NCT01395667 2016-11-10

Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy in Combination With Bevacizumab-FOLFOX

Phase 1 Completed

15 enrolled

Rectal Neoplasms

NCT01043484 2016-10-19

AVAXEL

90 enrolled

Rectal Neoplasms

NCT01320683 2016-07-19

Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer

1 enrolled 2 charts

Colonic Neoplasms, Rectal Neoplasms

NCT00571740 2016-07-06

Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer

Phase 2 Withdrawn

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00462501 2016-01-20

Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer

Phase NA Completed

35 enrolled 6 charts

Rectal Neoplasms, Colorectal Neoplasms

NCT00537901 2015-12-17

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

Phase NA Completed

100 enrolled

Colonic Neoplasms, Rectal Neoplasms

NCT00265824 2015-12-11

DREAM

Phase 3 Completed

700 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01205022 2015-06-08

Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Phase 1 Completed

3 enrolled

Colonic Neoplasms, Rectal Neoplasms

NCT01818973 2015-06-08

Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal Cancer

Phase 2 Unknown

45 enrolled

Rectal Neoplasms

NCT01375816 2015-06-04

PEPCOL

55 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00720512 2015-03-11

BEBYP

Phase 3 Terminated

184 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00543842 2015-02-26

Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer

Phase 1 Completed

19 enrolled

Rectal Neoplasms

NCT01554059 2014-11-10

New Beat

25 enrolled

Adenocarcinoma, Rectal Neoplasms

NCT00416494 2014-09-03

Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer

50 enrolled 12 charts

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01198548 2014-07-21

High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer

10 enrolled 6 charts